Information:
Error:
ID
12963
Description
Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00193050
Link
https://clinicaltrials.gov/show/NCT00193050
Keywords
Versions (1)
- 1/7/16 1/7/16 -
Uploaded on
January 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT00193050
Eligibility Breast Cancer NCT00193050
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00193050
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
biopsy adenocarcinoma
Item
adenocarcinoma of the breast confirmed by biopsy
boolean
C0005558 (UMLS CUI [1,1])
C0858252 (UMLS CUI [1,2])
C0858252 (UMLS CUI [1,2])
age, gender
Item
female patients >18 years of age
boolean
C0001779 (UMLS CUI [1])
C0079399 (UMLS CUI [2])
C0079399 (UMLS CUI [2])
cardiac function
Item
normal cardiac function
boolean
C0232164 (UMLS CUI [1])
performance status
Item
ability to perform activities of daily living with minimal assistance
boolean
C1518965 (UMLS CUI [1])
chemotherapy
Item
chemotherapy naïve or have received prior chemotherapy > 5 years ago
boolean
C0392920 (UMLS CUI [1])
bone marrow, liver and kidney function
Item
adequate bone marrow, liver and kidney function
boolean
C0232741 (UMLS CUI [1])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0005953 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
informed consent
Item
be informed of the investigational nature of this study
boolean
C0021430 (UMLS CUI [1])
informed consent
Item
sign an informed consent form
boolean
C0021430 (UMLS CUI [1])
sentinel lymph node, axillary dissection
Item
sentinel lymph node and/or axillary dissection prior to enrollment
boolean
C0024203 (UMLS CUI [1,1])
C1522495 (UMLS CUI [1,2])
C0193867 (UMLS CUI [2])
C1522495 (UMLS CUI [1,2])
C0193867 (UMLS CUI [2])
life expectancy
Item
life expectancy of < than 6 months
boolean
C0023671 (UMLS CUI [1])
heart disease
Item
history of significant heart disease
boolean
C0018799 (UMLS CUI [1])
chemotherapy, hormone therapy
Item
prior chemotherapy or hormonal therapy
boolean
C0392920 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0279025 (UMLS CUI [2])
trastuzumab
Item
concurrent trastuzumab therapy
boolean
C0338204 (UMLS CUI [1])
comorbidity
Item
history of significant psychiatric disorders
boolean
C0009488 (UMLS CUI [1,1])
C0004936 (UMLS CUI [1,2])
C0004936 (UMLS CUI [1,2])
infection
Item
history of active uncontrolled infection
boolean
C0009450 (UMLS CUI [1])
additional inclusion/exclusion criteria
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean